Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPM8 | Q7Z2W7 | 5/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | TRPV1 | Q8NER1 | 4/20 | 0.41 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10073868 | 0.86 | TRPM8 (0.73) | TRPM8SMN1; SMN2EPHX1TRPV1 | |
| SCHEMBL4817987 | 0.85 | TRPM8 (0.57) | TRPM8EPHX1 | |
| SCHEMBL14664188 | 0.85 | TRPM8 (0.57) | TRPM8EPHX1 | |
| SCHEMBL2628678 | 0.85 | TRPM8 (0.57) | TRPM8EPHX1 | |
| SCHEMBL15133483 | 0.85 | TRPM8 (0.57) | TRPM8EPHX1 | |
| SCHEMBL5391878 | 0.83 | TRPM8 (0.55) | TRPM8EPHX1TRPV1P2RX4 | |
| SCHEMBL15133431 | 0.83 | TRPM8 (0.55) | TRPM8SMN1; SMN2ALDH1A1KDM4EEPHX1 | |
| SCHEMBL2628685 | 0.83 | TRPM8 (0.55) | TRPM8ALDH1A1EPHX1LMNAHPGD | |
| SCHEMBL13989013 | 0.83 | TRPM8 (0.76) | TRPM8SMN1; SMN2ALDH1A1EPHX1TRPV1 | |
| SCHEMBL18105695 | 0.82 | SMN1; SMN2 (0.47) | TRPM8SMN1; SMN2ALDH1A1KDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080300314-A1 | Cooling Compounds | GIVAUDAN SA (CH) | 2008-12-04 | — | — | US | disclosed |
| US-20080300314-A1 | Cooling Compounds | GIVAUDAN SA (CH) | 2008-12-04 | — | — | US | disclosed |
| US-20080300314-A1 | Cooling Compounds | GIVAUDAN SA (CH) | 2008-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080300314-A1 | Cooling Compounds | TAS2R42, TAS2R4, TAS2R41 | TRPM8 73/4885SMN1; SMN2 976/4885ALDH1A1 2910/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.